1/15
03:15 pm
rhhby
Roche (OTCMKTS:RHHBY) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating.
Low
Report
Roche (OTCMKTS:RHHBY) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating.
1/13
07:21 am
rhhby
Magnet Biomedicine Expands Leadership with Appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer [Yahoo! Finance]
Low
Report
Magnet Biomedicine Expands Leadership with Appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer [Yahoo! Finance]
1/8
07:18 pm
rhhby
MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche [Yahoo! Finance]
Low
Report
MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche [Yahoo! Finance]
1/8
05:33 pm
rhhby
A Look At Roche Holding's (SWX:ROG) Valuation As TIGIT And AI Pathology Progress Draw Fresh Attention [Yahoo! Finance]
Low
Report
A Look At Roche Holding's (SWX:ROG) Valuation As TIGIT And AI Pathology Progress Draw Fresh Attention [Yahoo! Finance]
1/7
07:12 am
rhhby
Roche (OTCMKTS:RHHBY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Roche (OTCMKTS:RHHBY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
1/7
04:33 am
rhhby
Immunotherapy and AI Biomarker Advances Might Change The Case For Investing In Roche Holding (SWX:ROG) [Yahoo! Finance]
Low
Report
Immunotherapy and AI Biomarker Advances Might Change The Case For Investing In Roche Holding (SWX:ROG) [Yahoo! Finance]
1/6
12:00 pm
rhhby
Roche (OTCMKTS:RHHBY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Low
Report
Roche (OTCMKTS:RHHBY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
1/6
11:11 am
rhhby
U.S. Next Generation Sequencing Market Intelligence, Revenue Expansion, Key Players and Long-Term Growth Signals [Yahoo! Finance]
Low
Report
U.S. Next Generation Sequencing Market Intelligence, Revenue Expansion, Key Players and Long-Term Growth Signals [Yahoo! Finance]
1/6
08:52 am
rhhby
Ibex Medical Analytics Announces Expansion of its Biopharma Business, Extending AI Pathology Platform into Early Biomarker Development [Yahoo! Finance]
Low
Report
Ibex Medical Analytics Announces Expansion of its Biopharma Business, Extending AI Pathology Platform into Early Biomarker Development [Yahoo! Finance]
1/2
12:31 pm
rhhby
Corcept Tanks on FDA's CRL to Relacorilant NDA in Hypercortisolism [Yahoo! Finance]
Low
Report
Corcept Tanks on FDA's CRL to Relacorilant NDA in Hypercortisolism [Yahoo! Finance]
12/24
12:37 am
rhhby
Is FDA's Fast Subcutaneous Lunsumio VELO Approval Reshaping the Investment Case For Roche (SWX:ROG)? [Yahoo! Finance]
Low
Report
Is FDA's Fast Subcutaneous Lunsumio VELO Approval Reshaping the Investment Case For Roche (SWX:ROG)? [Yahoo! Finance]
12/22
01:14 am
rhhby
FDA approves Roche's Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma [Yahoo! Finance]
Medium
Report
FDA approves Roche's Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma [Yahoo! Finance]
12/22
01:00 am
rhhby
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
Medium
Report
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
12/20
09:41 pm
rhhby
Roche CEO points to higher future drug prices in Switzerland after US deal [Yahoo! Finance]
Medium
Report
Roche CEO points to higher future drug prices in Switzerland after US deal [Yahoo! Finance]
12/20
09:41 pm
rhhby
Does Roche Still Offer Value After a 35.9% Rally and New Oncology Partnerships? [Yahoo! Finance]
Medium
Report
Does Roche Still Offer Value After a 35.9% Rally and New Oncology Partnerships? [Yahoo! Finance]
12/20
04:45 pm
rhhby
Roche CEO points to higher future drug prices in Switzerland after US deal [Yahoo! Finance Canada]
Medium
Report
Roche CEO points to higher future drug prices in Switzerland after US deal [Yahoo! Finance Canada]
12/19
04:35 pm
rhhby
Nine Drugmakers Strike Deals With Trump, With More to Come [Yahoo! Finance Canada]
Low
Report
Nine Drugmakers Strike Deals With Trump, With More to Come [Yahoo! Finance Canada]
12/19
03:27 pm
rhhby
Year in Review: Pharmaceuticals industry continues ascent [Yahoo! Finance]
Low
Report
Year in Review: Pharmaceuticals industry continues ascent [Yahoo! Finance]
12/19
02:50 pm
rhhby
Genentech Announces Agreement With U.S. Government [Yahoo! Finance]
Low
Report
Genentech Announces Agreement With U.S. Government [Yahoo! Finance]
12/19
02:28 pm
rhhby
Genentech Announces Agreement With U.S. Government
Low
Report
Genentech Announces Agreement With U.S. Government
12/17
05:52 pm
rhhby
Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight [Yahoo! Finance]
Low
Report
Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight [Yahoo! Finance]
12/16
08:30 am
rhhby
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
Low
Report
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
12/16
02:17 am
rhhby
Calluna Pharma Announces the Appointment of Gijs van den Brink, MD, PhD, as Independent Director [Yahoo! Finance]
Low
Report
Calluna Pharma Announces the Appointment of Gijs van den Brink, MD, PhD, as Independent Director [Yahoo! Finance]
12/15
08:33 am
rhhby
Manifold Bio Expands Leadership Team to Drive its AI + In Vivo Targeted Biologics Platform [Yahoo! Finance]
Low
Report
Manifold Bio Expands Leadership Team to Drive its AI + In Vivo Targeted Biologics Platform [Yahoo! Finance]
12/12
05:05 am
rhhby
Zealand Pharma and OTR to develop metabolic disease therapeutics [Yahoo! Finance]
Low
Report
Zealand Pharma and OTR to develop metabolic disease therapeutics [Yahoo! Finance]